Patients with COVID-19 associated pneumonia, who received Actemra plus standard of care, were 44 percent less likely to progress to mechanical ventilation, or death, compared to patients who received placebo plus standard of careRoche’s Tocilizumab cuts likelihood of death in COVID-19 hospitalised patients with associated pneumonia by 44%
Patients with COVID-19 associated pneumonia, who received Actemra plus standard of care, were 44 percent less likely to progress to mechanical ventilation, or death, compared to patients who received placebo plus standard of care
Subscribe to:
Post Comments (Atom)
-
"The (latest) investment will be used to grow the mobile esports format and establish presence in select overseas markets through its ...
-
The NCLT#39;s Ahmedabad bench has directed the RP to include GAIL in the list of creditors for both the companies.
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment